Barber Daniel 4

What Happened Daniel Barber, President and CEO of Aquestive Therapeutics (AQST), sold 8,257 shares in an open-market transaction on May 15, 2026, for total proceeds of approximately $35,413. The filing reports a weighted-average price of $4.2889 per share; individual sale prices ranged from $4.17 to $4.64. This was a sale (not a purchase).

Key Details

• Transaction date: 2026-05-15; Form 4 filed: 2026-05-18.
• Transaction type: Open-market sale (code S).
• Shares sold: 8,257; weighted-average price: $4.2889; gross proceeds: ~$35,413.
• Footnote: Prices in the sale ranged $4.17–$4.64; the reporting person will provide a per-price breakdown upon request (footnote F1).
• Shares owned after the transaction: Not specified in the provided excerpt.
• Timeliness: Filing was submitted three days after the reported transaction date; check the SEC record for official timeliness classification.

Context Insider sales are often routine (for diversification, personal needs, or planned programs) and do not by themselves indicate management’s view of company prospects. There is no indication in this report of option exercise, award, gift, or tax-withholding related to these shares.